Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D06LLS
|
|||
Drug Name |
PMID25684022-Compound-WO2009153313
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Metastatic cancer [ICD-11: 2D50-2E2Z] | Patented | [1] | |
Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C76-C80; ICD-9: 140-229] | Patented | [1] | ||
Company |
NOVARTIS AG JAIN, Rama LIN, Xiaodong NG, Simon C. PFISTER, Keith B. RAMURTHY, Savithri RICO, Alice SUBRAMANIAN, Sharadha WANG, Xiaojing Michael
|
|||
Structure |
![]() |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Pyruvate dehydrogenase kinase 1 (PDHK1) | Target Info | Inhibitor | [1] |
Target's Patent Info | Pyruvate dehydrogenase kinase 1 (PDHK1) | Target's Patent Info | [1] | |
KEGG Pathway | HIF-1 signaling pathway | |||
Axon guidance | ||||
Central carbon metabolism in cancer |
References | Top | |||
---|---|---|---|---|
REF 1 | PDK1 disruptors and modulators: a patent review.Expert Opin Ther Pat. 2015 May;25(5):513-37. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.